Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies
Timothée Bruel, Jérôme Hadjadj, Piet Maes, View ORCID ProfileDelphine Planas, Aymeric Seve, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, William-Henry Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon-Loriere, Emmanuel André, View ORCID ProfileBenjamin Terrier, Thierry Prazuck, Olivier Schwartz
doi: https://doi.org/10.1101/2022.03.09.22272066
Timothée Bruel
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
2Vaccine Research Institute, 94000, Créteil, France
Jérôme Hadjadj
3Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France
Piet Maes
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Delphine Planas
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
2Vaccine Research Institute, 94000, Créteil, France
Aymeric Seve
5CHR d’Orléans, service de maladies infectieuses, Orléans, France
Isabelle Staropoli
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
Florence Guivel-Benhassine
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
Françoise Porrot
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
William-Henry Bolland
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
6Université de Paris, École doctorale BioSPC 562, 75013, Paris, France
Yann Nguyen
3Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France
Marion Casadevall
3Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France
Caroline Charre
7Université de Paris, Faculté de Médecine, Paris, France
8INSERM U1016, CNRS UMR8104, Institut Cochin, Paris, France
9AP-HP, Laboratoire de Virologie, CHU Cochin, Paris, France
Hélène Péré
10INSERM, Functional Genomics of Solid Tumors (FunGeST), Centre de Recherche des Cordeliers, Université de Paris and Sorbonne Université, Paris, France
11Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, Paris, France
David Veyer
10INSERM, Functional Genomics of Solid Tumors (FunGeST), Centre de Recherche des Cordeliers, Université de Paris and Sorbonne Université, Paris, France
11Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, Paris, France
Matthieu Prot
12G5 Evolutionary Genomics of RNA Viruses, Institut Pasteur, Université de Paris, Paris, France
Artem Baidaliuk
12G5 Evolutionary Genomics of RNA Viruses, Institut Pasteur, Université de Paris, Paris, France
Lize Cuypers
13University Hospitals Leuven, Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, Leuven, Belgium
Cyril Planchais
14Humoral Immunology Laboratory, Institut Pasteur, Université de Paris, INSERM U1222, Paris, France
Hugo Mouquet
14Humoral Immunology Laboratory, Institut Pasteur, Université de Paris, INSERM U1222, Paris, France
Guy Baele
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Luc Mouthon
3Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France
Laurent Hocqueloux
5CHR d’Orléans, service de maladies infectieuses, Orléans, France
Etienne Simon-Loriere
12G5 Evolutionary Genomics of RNA Viruses, Institut Pasteur, Université de Paris, Paris, France
Emmanuel André
13University Hospitals Leuven, Department of Laboratory Medicine, National Reference Centre for Respiratory Pathogens, Leuven, Belgium
15KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium
Benjamin Terrier
3Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP.CUP, Hôpital Cochin, Paris, France
Thierry Prazuck
5CHR d’Orléans, service de maladies infectieuses, Orléans, France
Olivier Schwartz
1Institut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015, Paris, France
2Vaccine Research Institute, 94000, Créteil, France
Data Availability
All data supporting the findings of this study are available within the article or from the corresponding authors upon request.
Posted March 12, 2022.
Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies
Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Seve, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, William-Henry Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon-Loriere, Emmanuel André, Benjamin Terrier, Thierry Prazuck, Olivier Schwartz
medRxiv 2022.03.09.22272066; doi: https://doi.org/10.1101/2022.03.09.22272066
Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies
Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Seve, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, William-Henry Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon-Loriere, Emmanuel André, Benjamin Terrier, Thierry Prazuck, Olivier Schwartz
medRxiv 2022.03.09.22272066; doi: https://doi.org/10.1101/2022.03.09.22272066
Subject Area
Subject Areas
- Addiction Medicine (228)
- Allergy and Immunology (506)
- Anesthesia (110)
- Cardiovascular Medicine (1245)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10032)
- Gastroenterology (500)
- Genetic and Genomic Medicine (2465)
- Geriatric Medicine (238)
- Health Economics (480)
- Health Informatics (1647)
- Health Policy (754)
- Hematology (250)
- HIV/AIDS (536)
- Medical Education (253)
- Medical Ethics (75)
- Nephrology (268)
- Neurology (2290)
- Nursing (139)
- Nutrition (352)
- Oncology (1249)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (325)
- Pediatrics (734)
- Primary Care Research (282)
- Public and Global Health (4844)
- Radiology and Imaging (843)
- Respiratory Medicine (652)
- Rheumatology (286)
- Sports Medicine (227)
- Surgery (269)
- Toxicology (44)
- Transplantation (125)
- Urology (99)